VRTX
Vertex Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.72 / 10
Netural
Analyst sentiment is mixed: 75% Strong Buy and 25% Buy, yet recent predictions have underperformed, yielding negative returns. Fund‑flow metrics are strong (7.68/10) with positive inflows across most sizes except large caps. The combined view remains neutral.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-10
InstitutionJefferies
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of VRTX?
- VRTX holds a Bearish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.72/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
